Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Investigation of affective input during object encoding in the perirhinal cortex

EmotionObjectCoding

In our everyday life, we ascribe certain emotional value to some objects. More specifically, we ascribe a valence to some objects, which is the degree to which something can be pleasurable or averse, leading to an emotional response when we interact or remember them. In the act of learning and remembering an object, the brain executes a complex set...

Funding Programme
Start Date
End Date
Total Funding
€ 226 751
European Countries Involved

Investigation of Cerebral Autosomal Dominant Arteriopathy with Sub-cortical Infarcts and Leukoencephalopathy (CADASIL) using induced pluripotent stem cell modelling and targeted therapeutic research

CADASIL-iMATTR

CADASIL, a rare disease of the small blood vessels, is caused by mutations in NOTCH3 and can cause cognitive decline leading to dementia. Vascular disease is the second most common cause of dementia with the burden set to increase with population aging. Insights into CADASIL will prove instrumental in understanding and treating the vascular...

Funding Programme
Start Date
End Date
Total Funding
€ 278 571
European Countries Involved

Janus Graphene supported Single atom catalysts for ultrasensitive cytokine point of care sensors

RESPONSE

Cytokines, such as TNF-, hold immense significance as protein biomarkers, pivotal for diagnostic, prognostic, and therapeutic management across various clinical disorders like Alzheimers disease, sepsis, and cancer. Nonetheless, prevailing techniques like enzyme-linked immunosorbent assay (ELISA) and Polymerase Chain Reaction (PCR) prove to be...

Funding Programme
Start Date
End Date
Total Funding
€ 166 278
European Countries Involved

Janus Graphene supported Single atom catalysts for ultrasensitive cytokine point of care sensors

RESPONSE

Cytokines, such as TNF-, hold immense significance as protein biomarkers, pivotal for diagnostic, prognostic, and therapeutic management across various clinical disorders like Alzheimers disease, sepsis, and cancer. Nonetheless, prevailing techniques like enzyme-linked immunosorbent assay (ELISA) and Polymerase Chain Reaction (PCR) prove to be...

Funding Programme
Start Date
End Date
Total Funding
€ 166 278
European Countries Involved

Kinase Regulation by Phase Separation

PhaseKin

Protein phosphorylation is a process that activates biological and cellular pathways. This process is carried out by enzymes called protein kinases that add phosphates to proteins. Protein kinases are crucial drug targets involved in the onset and progression of human diseases such as cancer and Alzheimers disease. Growing evidence suggests that...

Funding Programme
Start Date
End Date
Total Funding
€ 2 499 943
European Countries Involved

Label-free single-molecule detection of complex biomolecule interactions in free motion

LABIMO

Dysregulated interactions between biomolecules can lead to changes in cell signalling and gene expression, both common drivers of human disease. A detailed understanding of these interactions is vital for drug development, often targeting such interactions for therapeutic effects. In this project, I aim to develop an optical microscopy tool to...

Funding Programme
Start Date
End Date
Total Funding
€ 166 278
European Countries Involved

Large-scale and wide-band brain dynamics mediating memory consolidation in the freely moving rat

Wide-Band Ephys

Dementia is a major healthcare challenge worldwide due to its high incidence and its strong impact on the life quality of patients and on society as a whole. Development of treatments for the mitigation of memory impairment in patients with dementia has proven very challenging, partly due to our limited understanding of the underlying mechanisms of...

Funding Programme
Start Date
End Date
Total Funding
€ 313 118
European Countries Involved

Longitudinal multi-omic profiling to provide a molecular map of human stroke

MAP-STROKE

Stroke is a leading and increasingly important cause of death and disability in the EU. Yet, we have only few effective treatments and an unsatisfactory understanding of human stroke pathophysiology. Current diagnostic algorithms fail to capture pathophysiological mechanisms in daily clinical practice, hindering the allocation of patients to...

Funding Programme
Start Date
End Date
Total Funding
€ 202 125
European Countries Involved

Machine learning methods for the reconstruction of dual tracer PET images

Dual Tracer PET

Positron Emission Tomography (PET) is a medical imaging technique that displays in vivo brain-wide metabolic processes. Prior to PET image acquisition, a tracer, labelled with a positron emitting isotope, is injected to the patient. This so-called radiotracer distributes over the body and accumulates in e.g. inflammatory tissue. To date, the...

Funding Programme
Start Date
End Date
Total Funding
€ 189 687
European Countries Involved

MCH/COX2-depend regulation of neuronal function and neuroinflammation in Alzheimer’s disease

SynLip

Alzheimer’s disease (AD) patients stay in a prodromal phase over many years before robust cognitive decline. During this phase, complex molecular events lead to cellular alterations, resulting in aberrant synaptic activity and chronic inflammation which leads to neuronal death and cognitive impairment. My unpublished work, shows that melanin...

Funding Programme
Start Date
End Date
Total Funding
€ 1 567 785
European Countries Involved

Mechanism of protein kinases in biomolecular condensates

KinCond

Protein phosphorylation, mediated by kinases, plays a pivotal role in cellular regulation, with kinase dysregulation strongly associated with diseases like cancer, inflammation, and neurodegenerative disorders. Alzheimer's disease (AD) represents a significant global health challenge as the population ages at an accelerating pace. A key...

Funding Programme
Start Date
End Date
Total Funding
€ 173 847
European Countries Involved

Microbiome-Microglia interaction in Alzheimer's disease

MiMi-AD

Alzheimer’s disease (AD) affects over 55 million people worldwide, with no effective treatments currently available. Understanding early-stage mechanisms of the disease is critical to developing new therapeutic approaches. Microglial cells, key regulators of amyloid-beta (Aβ) clearance and neuroinflammation, are implicated in the progression of AD...

Funding Programme
Start Date
End Date
Total Funding
€ 226 420
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).